HomeCompareAPED vs JNJ

APED vs JNJ: Dividend Comparison 2026

APED yields 28.99% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APED wins by $104.8K in total portfolio value
10 years
APED
APED
● Live price
28.99%
Share price
$6.90
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$124.8K
Annual income
$16,029.67
Full APED calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — APED vs JNJ

📍 APED pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPEDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APED + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APED pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APED
Annual income on $10K today (after 15% tax)
$2,463.77/yr
After 10yr DRIP, annual income (after tax)
$13,625.22/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, APED beats the other by $12,921.61/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APED + JNJ for your $10,000?

APED: 50%JNJ: 50%
100% JNJ50/50100% APED
Portfolio after 10yr
$72.4K
Annual income
$8,428.73/yr
Blended yield
11.64%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

APED
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APED buys
0
JNJ buys
0
No recent congressional trades found for APED or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPEDJNJ
Forward yield28.99%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$124.8K$20.0K
Annual income after 10y$16,029.67$827.78
Total dividends collected$84.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: APED vs JNJ ($10,000, DRIP)

YearAPED PortfolioAPED Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$13,599$2,898.55$10,676$355.77+$2.9KAPED
2$18,234$3,683.75$11,407$389.39+$6.8KAPED
3$24,127$4,616.36$12,198$426.53+$11.9KAPED
4$31,524$5,708.63$13,056$467.62+$18.5KAPED
5$40,702$6,970.98$13,987$513.12+$26.7KAPED
6$51,963$8,411.62$14,998$563.56+$37.0KAPED
7$65,637$10,036.26$16,098$619.52+$49.5KAPED
8$82,079$11,847.88$17,295$681.69+$64.8KAPED
9$101,671$13,846.59$18,599$750.82+$83.1KAPED
10$124,818$16,029.67$20,022$827.78+$104.8KAPED

APED vs JNJ: Complete Analysis 2026

APEDStock

APED offers 200% exposure to the Bitcoin economy by combining MicroStrategy’s significant Bitcoin holdings with Coinbase’s role as a gateway to the crypto market.

Full APED Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this APED vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APED vs SCHDAPED vs JEPIAPED vs OAPED vs KOAPED vs MAINAPED vs ABBVAPED vs MRKAPED vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.